Status:
COMPLETED
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes
Lead Sponsor:
New England Retina Associates
Conditions:
Epiretinal Membrane
Age Related Macular Degeneration
Eligibility:
All Genders
58-90 years
Brief Summary
Study designed to evaluate the effect of significant ERM on the visual and anatomic outcomes of intravitreal anti-VEGF therapy for eAMD.
Detailed Description
Gass in 1987 described three cases of epiretinal membrane (ERM) associated with wet macular degeneration. Since then we have seen that is not rare to find the coexistence of these entities. An ERM may...
Eligibility Criteria
Inclusion
- Significant epiretinal membrane
- Anti-VEGF treatment for age-related macular degeneration
Exclusion
- Uveitis
- Macular disorders
- Diabetic retinopathy
- Vascular occlusions
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01846351
Start Date
July 1 2006
End Date
February 1 2010
Last Update
May 3 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.